In this multi-center , randomized , double-blind , double-dummy , active-controlled , parallel-group study , after 6-week open-label treatment with fluvastatin IR 40 mg once daily , patients who did not reach their lipid goals were randomized to 12-week double-blind treatment with fluvastatin XL 80 mg once daily or fluvastatin IR 40 mg twice daily .